SARS-CoV-2 Spike (S1) (COVID-19)
Catalogue Number: 544070-USB
| Manufacturer: | United States Biological |
| Type: | Monoclonal Primary Antibody - Unconjugated |
| Shipping Condition: | Blue Ice |
| Unit(s): | 100 ug, 200 ug |
| Host name: | Human |
| Clone: | CR3022 (recomb) |
| Isotype: | IgG1, kappa |
| Immunogen: | Peripheral blood lymphocytes of a patient exposed to the SARS-CoV. |
| Application: | ELISA, NT |
Description
Description: Recombinant monoclonal antibody to SARS-CoV-2 Spike with variable regions (i.e., specificity) from the B-cell clone CR3022. Manufactured using a proprietary recombinant platform technology. On 31 December 2019, the World Health Organization (WHO) was alerted of an outbreak of pneumonia in Wuhan City, China, caused by an unknown virus. The virus was sequenced and identified as a novel strain of Coronavirus one week later on 7 January 2020. It belongs to the same family of viruses which include Severe Acute Respiratory Syndrome (SARS) and Middle Eastern Respiratory Syndrome (MERS). 2019-nCoV is a positive-sense, single-stranded RNA virus which is thought to be of zoonotic origin. Symptoms of those infected include fever, dry cough, fatigue, shortness of breath and respiratory distress. Additionally, cases have resulted in renal failure, pneumonia and death. Those most seriously affected are individuals with already impaired immune systems, however approximately one quarter of otherwise well patients have required intensive care upon hospital admission. Human-to-human transmission of the virus has been confirmed, with previous Coronavirus outbreaks (such as SARS) originating from similar environments in Asian markets, where humans and live animals are in close proximity.
Additional Text
Uniprot ID
P59594
Purification
Protein A purified
Antibody Clonality
Monoclonal
544070 Datasheet
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations